Position in FHTX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,511,700
+$193,018 QoQ
Shares Held
309,775
+12.3% QoQ
Ownership
0.522%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 102 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in FHTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,813,607,781 across 424 Biotechnology names. FHTX ranks #250 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in FHTX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,511,700 | 309,775 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $1,318,682 | 275,875 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $1,417,121 | 262,430 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $1,390,230 | 284,301 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $1,347,489 | 286,700 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $902,663 | 247,305 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,197,325 | 253,671 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $2,334,928 | 250,798 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,097,968 | 190,951 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,310,073 | 195,242 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $1,285,316 | 199,274 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,006,555 | 201,311 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,423,241 | 202,165 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,153,665 | 186,075 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,157,414 | 181,413 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,579,997 | 184,149 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,543,172 | 186,998 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $2,565,676 | 168,462 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $3,898,785 | 170,476 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $2,438,752 | 175,072 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,738,141 | 162,900 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,111,020 | 84,296 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $1,792,637 | 88,438 | Shares | Defined | 2021-02-11 | |
| No filing history on record for this holder in this stock. | ||||||